1. Home
  2. SILO vs JXG Comparison

SILO vs JXG Comparison

Compare SILO & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • JXG
  • Stock Information
  • Founded
  • SILO 2010
  • JXG N/A
  • Country
  • SILO United States
  • JXG China
  • Employees
  • SILO N/A
  • JXG N/A
  • Industry
  • SILO Apparel
  • JXG
  • Sector
  • SILO Consumer Discretionary
  • JXG
  • Exchange
  • SILO Nasdaq
  • JXG Nasdaq
  • Market Cap
  • SILO 4.7M
  • JXG 5.2M
  • IPO Year
  • SILO N/A
  • JXG N/A
  • Fundamental
  • Price
  • SILO $1.96
  • JXG $2.77
  • Analyst Decision
  • SILO
  • JXG
  • Analyst Count
  • SILO 0
  • JXG 0
  • Target Price
  • SILO N/A
  • JXG N/A
  • AVG Volume (30 Days)
  • SILO 9.0M
  • JXG 139.0K
  • Earning Date
  • SILO 02-14-2025
  • JXG 12-06-2024
  • Dividend Yield
  • SILO N/A
  • JXG N/A
  • EPS Growth
  • SILO N/A
  • JXG N/A
  • EPS
  • SILO N/A
  • JXG 2.20
  • Revenue
  • SILO $72,102.00
  • JXG $38,490,872.00
  • Revenue This Year
  • SILO $1.86
  • JXG N/A
  • Revenue Next Year
  • SILO N/A
  • JXG N/A
  • P/E Ratio
  • SILO N/A
  • JXG $1.26
  • Revenue Growth
  • SILO N/A
  • JXG N/A
  • 52 Week Low
  • SILO $0.77
  • JXG $0.75
  • 52 Week High
  • SILO $4.50
  • JXG $8.51
  • Technical
  • Relative Strength Index (RSI)
  • SILO 79.84
  • JXG N/A
  • Support Level
  • SILO $1.62
  • JXG N/A
  • Resistance Level
  • SILO $2.16
  • JXG N/A
  • Average True Range (ATR)
  • SILO 0.31
  • JXG 0.00
  • MACD
  • SILO 0.10
  • JXG 0.00
  • Stochastic Oscillator
  • SILO 43.37
  • JXG 0.00

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About JXG JX Luxventure Limited Common Stock

JX Luxventure Group Inc, formerly JX Luxventure Ltd is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Airline tickets and tourism services, Software Solutions for Tourism Cross-border operation, and Tourism Cross-border Merchandise. The majority of the group revenue is generated from Tourism products.

Share on Social Networks: